Browse All

Current Filters

CLEAR FILTER x

TITLE

Long-term Maintenance of =50% Migraine Response with Eptinezumab Treatment in Patients with 2–4 Prior Preventive Migraine Treatment Failures

Author:Ailani, Jessica   Soni-Brahmbhatt, Seema   Awad, Susanne   Lee, Xin Ying   Sperling, Bjorn   Lipton, Richard B.   

Session Name:S22: Advances in Migraine and Therapeutics  

Topic:Headache  

Program Number:S22.008  

Author Institution:Georgetown University Hospital, Washington, DC  Lundbeck LLC, Deerfield, IL  H. Lundbeck A/S, Copenhagen, Denmark  Albert Einstein College of Medicine, Bronx, NY  

Treatment with Eptinezumab Reduces Brain Fog and Increases the Number of Good Days Per Month in Patients with Chronic Migraine in a Real-world Setting

Author:Buse, Dawn   Soni-Brahmbhatt, Seema   Asher, Divya   Lipton, Richard B.   

Session Name:P8: Headache: Advances in CGRP Inhibition 2  

Topic:Headache  

Program Number:P8.009  

Author Institution:Albert Einstein College of Medicine, Bronx, NY  Lundbeck LLC, Deerfield, IL